Cargando…
Short-Term Changes in Intraocular Pressure After Intravitreal Injection of Bevacizumab for the Treatment of Retinopathy of Prematurity
PURPOSE: To evaluate short-term changes in intraocular pressure after intravitreal injection of bevacizumab for retinopathy of prematurity. PATIENTS AND METHODS: This study was a prospective case-series. Consecutive infants underwent intravitreal injection with bevacizumab for type 1 retinopathy of...
Autores principales: | Obata, Shumpei, Higashiyama, Tomoaki, Imamura, Taku, Kakinoki, Masashi, Yanagi, Takahide, Maruo, Yoshihiro, Ohji, Masahito |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6911314/ https://www.ncbi.nlm.nih.gov/pubmed/31849442 http://dx.doi.org/10.2147/OPTH.S229708 |
Ejemplares similares
-
Effect of intravitreal bevacizumab for retinopathy of prematurity on weight gain
por: Obata, Shumpei, et al.
Publicado: (2021) -
Systemic adverse events after screening of retinopathy of prematurity with mydriatic
por: Obata, Shumpei, et al.
Publicado: (2021) -
Changes in fetal growth restriction and retinopathy of prematurity during the coronavirus disease 2019 pandemic: A cross-sectional study
por: Obata, Shumpei, et al.
Publicado: (2022) -
Usefulness of Intravitreal Bevacizumab for Retinopathy of Prematurity with Severely Dilated Tunica Vasculosa Lentis and Poor Mydriasis
por: Higashiyama, Tomoaki, et al.
Publicado: (2017) -
Comparison of single injection and three monthly injections of intravitreal bevacizumab for macular edema associated with branch retinal vein occlusion
por: Ito, Yuka, et al.
Publicado: (2015)